Skip to main content
Log in

Menotropin cost effective for ART in France

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Notes

  1. 2016 euros

Reference

  • Barriere P, et al. Cost-Effectiveness Analysis of the Gonadotropin Treatments HP-hMG and rFSH for Assisted Reproductive Technology in France: A Markov Model Analysis. Applied Health Economics and Health Policy : 9 Nov 2017. Available from: URL: http://doi.org/10.1007/s40258-017-0361-7

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Menotropin cost effective for ART in France. PharmacoEcon Outcomes News 792, 19 (2017). https://doi.org/10.1007/s40274-017-4542-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-017-4542-2

Navigation